Lv51
1438 积分 2022-10-24 加入
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
1小时前
已完结
B7-H3 antibody–drug conjugate turning immune evasion into vulnerability
18天前
已完结
A Newly Designed Antibody–drug Conjugate Targeting B7-H3 Demonstrates Enhanced Therapeutic Efficacy Across a Spectrum of Cancers
18天前
已完结
Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments
1个月前
已完结
Ifinatamab deruxtecan, a B7-H3-directed antibody–drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trial
1个月前
已完结
Impact of IBI3017, an innovative bispecific anti-Trop2 and B7H3 antibody-drug conjugate, on anti-tumor efficacy in a wide range of tumors
1个月前
已关闭
Abstract LB525: Discovery and characterization of ABSK111, a selective, CNS-penetrable, and broad-spectrum EGFR inhibitor targeting exon20 insertion, atypical and extracellular mutations
2个月前
已关闭
Exploring 4th generation EGFR inhibitors: A review of clinical outcomes and structural binding insights
2个月前
已完结
From challenges to solutions: A review of fourth-generation EGFR tyrosine kinase inhibitors to overcome the C797S triple mutation in non-small cell lung cancer
2个月前
已完结
A clinical review on third and fourth generation EGFR tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
2个月前
已完结
皖公网安备34019202002308
